Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Current status of Mycobacterium avium subspecies paratuberculosis infection in animals & humans in India: What needs to be done?

Singh AV, Chauhan DS, Singh SV, Kumar V, Singh A, Yadav A, Yadav VS.

Indian J Med Res. 2016 Nov;144(5):661-671. doi: 10.4103/ijmr.IJMR_1401_14. Review.

2.

Recent advances in understanding and managing Crohn's disease.

Stange EF, Wehkamp J.

F1000Res. 2016 Dec 21;5:2896. doi: 10.12688/f1000research.9890.1. eCollection 2016. Review.

3.

Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.

Newman KM, Rank KM, Vaughn BP, Khoruts A.

Gut Microbes. 2017 May 4;8(3):303-309. doi: 10.1080/19490976.2017.1279377. Epub 2017 Jan 19.

PMID:
28102756
4.

Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.

Menozzi A, Dall'Aglio M, Quintavalla F, Dallavalle L, Meucci V, Bertini S.

BMC Vet Res. 2016 Oct 6;12(1):217.

5.

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.

Matijašić M, Meštrović T, Perić M, Čipčić Paljetak H, Panek M, Vranešić Bender D, Ljubas Kelečić D, Krznarić Ž, Verbanac D.

Int J Mol Sci. 2016 Apr 19;17(4). pii: E578. doi: 10.3390/ijms17040578. Review.

6.

Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Leitner GC, Vogelsang H.

World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):5-20. doi: 10.4292/wjgpt.v7.i1.5. Review.

7.

Current therapy of pediatric Crohn's disease.

Lahad A, Weiss B.

World J Gastrointest Pathophysiol. 2015 May 15;6(2):33-42. doi: 10.4291/wjgp.v6.i2.33. Review.

8.

Classical and recent advances in the treatment of inflammatory bowel diseases.

Sales-Campos H, Basso PJ, Alves VB, Fonseca MT, Bonfá G, Nardini V, Cardoso CR.

Braz J Med Biol Res. 2015 Feb;48(2):96-107. doi: 10.1590/1414-431X20143774. Epub 2014 Nov 28. Review.

9.

Perturbation of the human microbiome as a contributor to inflammatory bowel disease.

Missaghi B, Barkema HW, Madsen KL, Ghosh S.

Pathogens. 2014 Jun 30;3(3):510-27. doi: 10.3390/pathogens3030510. Review.

10.

Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

Bringiotti R, Ierardi E, Lovero R, Losurdo G, Di Leo A, Principi M.

World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):550-9. doi: 10.4291/wjgp.v5.i4.550. Review.

11.

Use of antibiotics in the treatment of Crohn's disease.

Scribano ML, Prantera C.

World J Gastroenterol. 2013 Feb 7;19(5):648-53. doi: 10.3748/wjg.v19.i5.648. Review.

12.

The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.

Ferreira RB, Gill N, Willing BP, Antunes LC, Russell SL, Croxen MA, Finlay BB.

PLoS One. 2011;6(5):e20338. doi: 10.1371/journal.pone.0020338. Epub 2011 May 25.

13.

Current and emerging drugs for the treatment of inflammatory bowel disease.

Triantafillidis JK, Merikas E, Georgopoulos F.

Drug Des Devel Ther. 2011 Apr 6;5:185-210. doi: 10.2147/DDDT.S11290. Review.

14.

Role of conventional therapies in the era of biological treatment in Crohn's disease.

Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, Fornarini GS, Riso D, Campieri M, Rizzello F.

World J Gastroenterol. 2011 Apr 14;17(14):1797-806. doi: 10.3748/wjg.v17.i14.1797. Review.

15.

Crohn's disease.

Mills SC, von Roon AC, Tekkis PP, Orchard TR.

BMJ Clin Evid. 2011 Apr 27;2011. pii: 0416. Review.

16.

Crohn's disease.

von Roon AC, Reese GE, Orchard TR, Tekkis PP.

BMJ Clin Evid. 2007 Nov 7;2007. pii: 0416. Review.

17.

Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease.

Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, Dutt S, Stormon M, Otley A, O'Loughlin EV, Magoffin A, Ng PH, Mitchell H.

J Clin Microbiol. 2009 Feb;47(2):453-5. doi: 10.1128/JCM.01949-08. Epub 2008 Dec 3.

18.

Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

De Hertogh G, Aerssens J, Geboes KP, Geboes K.

World J Gastroenterol. 2008 Feb 14;14(6):845-52. Review.

19.

Antibiotic therapy for Crohn's disease: a review.

Lal S, Steinhart AH.

Can J Gastroenterol. 2006 Oct;20(10):651-5. Review.

20.

Conventional therapy for Crohn's disease.

Büning C, Lochs H.

World J Gastroenterol. 2006 Aug 14;12(30):4794-806. Review.

Supplemental Content

Support Center